Reference SummaryWard JM, J Natl Cancer Inst 1979 Sep;63(3):849-54
Title |
Neoplastic and nonneoplastic lesions in aging (C57BL/6N x C3H/HeN)F1 (B6C3F1) mice. |
Authors |
Ward JM; Goodman DG; Squire RA; Chu KC; Linhart MS |
Journal |
J Natl Cancer Inst |
Volume |
63 |
Issue |
3 |
Year |
1979 |
Pages |
849-54 |
Abstract |
Neoplastic and nonneoplastic lesions in untreated (C57BL/6N x C3H/HeN)F1 (B6C3F1) mice used as controls in carcinogenesis tests were tabulated and evaluated. The most common neoplasms in 2,543 male mice were hepatocellular adenomas and carcinomas. In 2,522 female mice, common tumors were lymphomas, leukemias, pulmonary adenomas and carcinomas, hepatocellular adenomas and carcinomas, and pituitary adenomas. The risk of developing most neoplasms increased with the age of the mouse. Hepatocellular carcinomas metastasized in 12% of the animals with these tumors. Other than lymphomas and leukemias, few other tumors metastasized. Nonneoplastic lesions included cystic hyperplasia of the uterus, nephritis, ovarian and uterine cysts, inflammatory lesions of the lung, mineralization in the brain, and focal hyperplasias in several tissues. The focal hyperplasias in lung and pituitary, adrenal, and thyroid glands were suggestive of the early stages of neoplasia. Comparative aspects of lesions in aging mice and their interpretation in carcinogenesis tests are discussed. |
Links |
J:27160 – MGI References 288939 – National Library of Medicine/PubMed |
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
(C57BL/6N x C3H/HeN)F1 | Adipose tissue lipoma | Skin |
0.12 - 0.16 |
||
(C57BL/6N x C3H/HeN)F1 | Adipose tissue lipoma | Urinary bladder |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Adipose tissue lipoma | Ovary |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Adipose tissue liposarcoma | Skin |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Adrenal gland - Cortex adenoma | Adrenal gland - Cortex |
0.36 - 0.55 |
||
(C57BL/6N x C3H/HeN)F1 | Adrenal gland - Cortex carcinoma | Adrenal gland - Cortex |
0 - 0.12 |
||
(C57BL/6N x C3H/HeN)F1 | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
0.28 - 0.31 |
||
(C57BL/6N x C3H/HeN)F1 | Adrenal gland hyperplasia | Adrenal gland |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Adrenal gland hyperplasia - focal | Adrenal gland |
3.85 - 5.15 |
||
(C57BL/6N x C3H/HeN)F1 | Adrenal gland preneoplastic lesion | Adrenal gland |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangioma | Spleen |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangioma | Liver |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangioma | Skin |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangioma | Lymph node |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangioma | (Unspecified organ) |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangioma | Blood vessel |
0.79 - 1.3 |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangiosarcoma | Spleen |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangiosarcoma | Liver |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangiosarcoma | Skin |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangiosarcoma | Lymph node |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangiosarcoma | (Unspecified organ) |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangiosarcoma | Blood vessel |
1.11 - 1.61 |
||
(C57BL/6N x C3H/HeN)F1 | Bone osteochondroma | Bone |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Bone osteoma | Lung |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Bone osteosarcoma | Skin |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Bone osteosarcoma | Lung |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Bone osteosarcoma | Bone |
0.04 - 0.16 |
||
(C57BL/6N x C3H/HeN)F1 | CNS - Brain - Oligodendroglial cell oligodendroglioma | CNS - Brain - Oligodendroglial cell |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | CNS - Brain glioma | CNS - Brain |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | CNS - Meninges meningioma | CNS - Meninges |
0 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Connective tissue - Fibroblast fibroadenoma | Mammary gland |
0 - 0.12 |
||
(C57BL/6N x C3H/HeN)F1 | Connective tissue - Fibroblast fibroma | Skin |
0.04 - 0.31 |
||
(C57BL/6N x C3H/HeN)F1 | Connective tissue - Fibroblast fibroma | Pancreas |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Connective tissue - Fibroblast fibrosarcoma | Skin |
0.56 - 0.87 |
||
(C57BL/6N x C3H/HeN)F1 | Connective tissue - Fibroblast fibrosarcoma | Kidney |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Esophagus papilloma | Esophagus |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Esophagus squamous cell carcinoma | Esophagus |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Eye - Harderian gland adenoma | Eye - Harderian gland |
0.44 - 0.75 |
||
(C57BL/6N x C3H/HeN)F1 | Eye - Lacrimal gland adenoma | Eye - Lacrimal gland |
0.08 - 0.16 |
||
(C57BL/6N x C3H/HeN)F1 | Eye melanoma - malignant | Eye |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Intestine - Small Intestine adenocarcinoma | Intestine - Small Intestine |
0.04 - 0.28 |
||
(C57BL/6N x C3H/HeN)F1 | Intestine - Small Intestine adenoma | Intestine - Small Intestine |
0.04 - 0.16 |
||
(C57BL/6N x C3H/HeN)F1 | Kidney - Renal tubule adenocarcinoma - tubular | Kidney - Renal tubule |
0.04 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Kidney - Renal tubule adenoma - tubular | Kidney - Renal tubule |
0 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Lymphocyte lymphoma | Leukocyte - Lymphocyte |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Lymphocyte lymphoma | Lymph node |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Lymphocyte lymphoma | Spleen |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Lymphocyte lymphoma | Liver |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Lymphocyte lymphoma | Peyer's patch |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Lymphocyte lymphoma - lymphocytic | Leukocyte - Lymphocyte |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Lymphocyte lymphoma - mixed | Leukocyte - Lymphocyte |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell tumor | (Unspecified organ) |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) |
0.24 |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte leukemia | Lymph node |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte leukemia | Spleen |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte leukemia | Liver |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte leukemia | (Unspecified organ) |
8.3 - 16.77 |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte lymphoma | (Unspecified organ) |
8.3 - 16.77 |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte lymphoma - histiocytic | Leukocyte |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Liver carcinoma - undifferentiated | Liver |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular adenoma | Liver |
1.59 - 7.9 |
||
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular carcinoma | Liver |
2.3 - 13.72 |
||
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular neoplasm | Liver |
3.9 - 21.6 |
||
(C57BL/6N x C3H/HeN)F1 | Liver hepatoma | Liver |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Liver hyperplasia - adenomatous | Liver |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Liver lesion | Liver |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Liver tumor | Liver |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Lung - Alveolus hyperplasia - epithelial | Lung - Alveolus |
0.56 - 0.83 |
||
(C57BL/6N x C3H/HeN)F1 | Lung adenoma | Lung |
observed - 7.79 |
||
(C57BL/6N x C3H/HeN)F1 | Lung carcinoma | Lung |
observed - 5.03 |
||
(C57BL/6N x C3H/HeN)F1 | Lung hyperplasia | Lung |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Lung neoplasm | Lung |
4.4 - 12.7 |
||
(C57BL/6N x C3H/HeN)F1 | Lung preneoplastic lesion | Lung |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Lymph node hyperplasia | Lymph node |
4.12 - 4.25 |
||
(C57BL/6N x C3H/HeN)F1 | Lymphoid tissue hyperplasia - lymphoid | Lung |
7.43 - 10.86 |
||
(C57BL/6N x C3H/HeN)F1 | Mammary gland adenoma | Mammary gland |
0 - 0.12 |
||
(C57BL/6N x C3H/HeN)F1 | Mammary gland carcinoma | Mammary gland |
0 - 0.59 |
||
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma | Skin |
0.12 - 0.16 |
||
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma | Lung |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma | Intestine - Small Intestine |
0.04 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma | Uterus |
0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma | Vagina |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma | Abdominal cavity |
0 - 0.12 |
||
(C57BL/6N x C3H/HeN)F1 | Mesodermal cell/mesoblast sarcoma | Thoracic cavity |
0 - 0.12 |
||
(C57BL/6N x C3H/HeN)F1 | Mesothelium mesothelioma | Abdominal cavity |
0 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Mesothelium mesothelioma | Thoracic cavity |
0 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Muscle - Smooth leiomyoma | Uterus |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Muscle - Smooth leiomyosarcoma | Skin |
0.08 - 0.12 |
||
(C57BL/6N x C3H/HeN)F1 | Muscle - Smooth leiomyosarcoma | Intestine - Large Intestine |
0 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Muscle - Smooth leiomyosarcoma | Uterus |
0.2 |
||
(C57BL/6N x C3H/HeN)F1 | Muscle - Striated - Skeletal rhabdomyosarcoma | Muscle - Striated - Skeletal |
0 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Myoepithelial cell myoepithelioma | Mammary gland |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
0.12 |
||
(C57BL/6N x C3H/HeN)F1 | Ovary - Hilus cell tumor | Ovary - Hilus cell |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Ovary adenocarcinoma | Ovary |
0.12 |
||
(C57BL/6N x C3H/HeN)F1 | Ovary adenoma - papillary | Ovary |
0.28 |
||
(C57BL/6N x C3H/HeN)F1 | Ovary adenoma - tubular | Ovary |
0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Ovary cyst | Ovary |
11.38 |
||
(C57BL/6N x C3H/HeN)F1 | Ovary lesion | Ovary |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Ovary luteoma | Ovary |
0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Oviduct lesion | Oviduct |
observed |
||
(C57BL/6N x C3H/HeN)F1 | PNS - Schwann cell neurofibrosarcoma | Skin |
0.04 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | PNS - Schwann cell neurofibrosarcoma | Intestine - Large Intestine |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | PNS - Schwann cell schwannoma | Skin |
0.04 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | PNS - Schwann cell schwannoma | PNS - Schwann cell |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Pancreas - Duct cyst | Pancreas - Duct |
0.2 - 0.75 |
||
(C57BL/6N x C3H/HeN)F1 | Pancreas - Islet of Langerhans adenoma | Pancreas - Islet of Langerhans |
0.08 - 0.28 |
||
(C57BL/6N x C3H/HeN)F1 | Pancreas - Islet of Langerhans carcinoma | Pancreas - Islet of Langerhans |
0 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Pancreas - Islet of Langerhans hyperplasia | Pancreas - Islet of Langerhans |
0.2 - 1.57 |
||
(C57BL/6N x C3H/HeN)F1 | Pancreas adenoma | Pancreas |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Parathyroid gland adenoma | Parathyroid gland |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Pituitary gland adenoma | Pituitary gland |
0.12 - 3.01 |
||
(C57BL/6N x C3H/HeN)F1 | Pituitary gland carcinoma | Pituitary gland |
0.08 - 0.16 |
||
(C57BL/6N x C3H/HeN)F1 | Pituitary gland hyperplasia | Pituitary gland |
observed - 0.36 |
||
(C57BL/6N x C3H/HeN)F1 | Pituitary gland preneoplastic lesion | Pituitary gland |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Prostate gland adenocarcinoma | Prostate gland |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Renal pelvis - Transitional cell papilloma | Renal pelvis - Transitional cell |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Seminal vesicle adenoma - papillary | Seminal vesicle |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Skin - Epidermis - Basal cell carcinoma - basal | Skin - Epidermis - Basal cell |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Skin - Hair follicle - Basal cell trichoepithelioma | Skin - Hair follicle - Basal cell |
0 |
||
(C57BL/6N x C3H/HeN)F1 | Skin - Melanocyte melanoma - malignant | Skin - Melanocyte |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Skin adenocarcinoma | Skin |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Skin adenoma - sebaceous | Skin |
0 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Skin keratoacanthoma | Skin |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Skin lesion | Skin |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Skin papilloma | Skin |
0.04 - 0.12 |
||
(C57BL/6N x C3H/HeN)F1 | Skin squamous cell carcinoma | Skin |
0.04 - 0.12 |
||
(C57BL/6N x C3H/HeN)F1 | Stomach carcinoma | Stomach |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Stomach hyperplasia | Stomach |
0.75 - 0.87 |
||
(C57BL/6N x C3H/HeN)F1 | Stomach papilloma | Stomach |
0.28 - 0.31 |
||
(C57BL/6N x C3H/HeN)F1 | Stomach polyp - adenomatous | Stomach |
0.04 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Stomach squamous cell carcinoma | Stomach |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Testis - Germ cell carcinoma - embryonal | Testis - Germ cell |
0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Testis - Germ cell seminoma | Testis - Germ cell |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Testis - Leydig cell (Interstitial cell) tumor | Testis - Leydig cell (Interstitial cell) |
0.28 |
||
(C57BL/6N x C3H/HeN)F1 | Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell |
0.63 - 1.19 |
||
(C57BL/6N x C3H/HeN)F1 | Thyroid gland - Follicular cell carcinoma | Thyroid gland - Follicular cell |
0.24 - 0.28 |
||
(C57BL/6N x C3H/HeN)F1 | Thyroid gland - Follicular cell hyperplasia - cystic | Thyroid gland - Follicular cell |
0.9 - 1.23 |
||
(C57BL/6N x C3H/HeN)F1 | Thyroid gland - Follicular cell hyperplasia - follicular | Thyroid gland - Follicular cell |
0.59 - 1.55 |
||
(C57BL/6N x C3H/HeN)F1 | Thyroid gland - Medulla - C cell adenoma | Thyroid gland - Medulla - C cell |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Thyroid gland - Medulla - C cell carcinoma | Thyroid gland - Medulla - C cell |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Thyroid gland hyperplasia | Thyroid gland |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Thyroid gland preneoplastic lesion | Thyroid gland |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Urethra adenoma | Urethra |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Urinary bladder adenoma - papillary | Urinary bladder |
0 - 0.04 |
||
(C57BL/6N x C3H/HeN)F1 | Urinary bladder hyperplasia - epithelial | Urinary bladder |
1.15 - 1.26 |
||
(C57BL/6N x C3H/HeN)F1 | Urinary bladder papilloma | Urinary bladder |
0 - 0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Uterus - Endometrium - Stroma polyp | Uterus - Endometrium - Stroma |
0.52 |
||
(C57BL/6N x C3H/HeN)F1 | Uterus adenocarcinoma | Uterus |
0.08 |
||
(C57BL/6N x C3H/HeN)F1 | Uterus adenoma | Uterus |
0.24 |
||
(C57BL/6N x C3H/HeN)F1 | Uterus cyst | Uterus |
5.79 |
||
(C57BL/6N x C3H/HeN)F1 | Uterus hyperplasia | Uterus |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Uterus hyperplasia - cystic | Uterus |
35.01 |
||
(C57BL/6N x C3H/HeN)F1 | Uterus lesion | Uterus |
observed |
||
(C57BL/6N x C3H/HeN)F1 | Vagina squamous cell carcinoma | Vagina |
0.04 |
||
(C57BL/6N x C3H/HeN)F1 | (Unspecified organ) neoplasm | (Unspecified organ) |
observed |